Basilea Pharmaceutica (BPMUF)
(Delayed Data from OTC)
$44.45 USD
0.00 (0.00%)
Updated Apr 10, 2024 01:56 PM ET
1-Strong Buy of 5 1
C Value D Growth C Momentum D VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 31% (78 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.35 | 9.99 |
Current Quarter Estimate | NA | 2.87 | 57.00 |
Year Ago Quarter Estimate | NA | -5.36 | 52.54 |
Next Quarter Estimate | NA | 7.43 | 61.00 |
Next Year Estimate | 2.98 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 153.13 | 13.00 | 15.67 |
Next Year | 22.63 | 7.80 | 9.31 |
Last 5 Years | NA | 1.00 | 8.10 |
Next 5 Years | NA | 20.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | NA | 1.99 |
Price/Cash Flow (MRFY) | 39.34 | 14.06 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | 1.76% |
Return on Equity (TTM) | NA | -12.43% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.